Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-16

Clinical Trial Update: Analgesic Treatment Mediated by Arcoxia (0663-093) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update of an analgesic treatment mediated by Arcoxia (etodolac? actually Arcoxia is etoricoxib) in pain management, status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Arcoxia (Etoricoxib)

Snippet

Sponsor: Organon and Co | Conditions: Pain | Phase 4 | Status: COMPLETED